v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (5,257,028) $ (3,519,440)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation expense 42,381 92,193  
Amortization of intangible assets 3,417 46,119  
Amortization of deferred license costs 30,589 10,196  
Amortization of debt issuance costs and debt discount 626,978 169,040  
Amortization of right of use asset 156,338 230,690  
Common stock issued for services 437,325  
SG DevCorp equity transactions 2,594,806  
Interest income on long-term note receivable (9,247)  
Stock-based compensation 179,029 656,369  
Changes in operating assets and liabilities:      
Accounts receivable 89,571 268,284  
Contract assets (864,333)  
Inventories (127,081) 452,571  
Prepaid expenses and other current assets (16,444) (522,314)  
Intangible assets (30,730) (81,180)  
Accounts payable and accrued expenses 1,281,640 1,691,992  
Contract liabilities (876,302) (93,142)  
Lease liability (277,521) (343,808)  
Customer deposit 656,510  
Net cash used in operating activities (923,847) (1,378,685)  
Cash flows from investing activities:      
Purchase of property, plant and equipment (31,842) (531,083)  
Cash from business combination 1,082  
Project development costs (226,426) (82,265)  
Investment in and advances to equity affiliates (25,000)  
Net cash used in investing activities (257,186) (638,348)  
Cash flows from financing activities:      
Repayment of short term notes payable (884,485) (2,500,000)  
Proceeds from short-term notes payable and warrants, net of debt issuance costs 2,293,644 5,433,175  
Proceeds from warrant inducement 494,213  
Distribution paid to non-controlling interest (46,417)  
Net cash provided by financing activities 1,903,372 2,886,758  
Net increase in cash and cash equivalents 722,339 869,725  
Cash and cash equivalents - beginning of period 17,448 582,776 $ 582,776
Cash and cash equivalents - end of period 739,787 1,452,501 $ 17,448
Supplemental disclosure of non-cash investing and financing activities:      
Peak Stock and Warrants Issuances 251,361  
Common stock deemed dividend 670,881  
Conversion of short-term notes payable to common stock 1,000,000  
Assets and liabilities acquired in business combination [Abstract]      
Intangible assets 100,468  
Goodwill 1,810,787  
Accounts payable and accrued expenses 32,237  
Contingent consideration payable $ 945,000  

Source

HTML PDF
XBRL
ZIP